214 related articles for article (PubMed ID: 31337239)
1. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization.
Ouchene L; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2019; 23(4):455-456. PubMed ID: 31337239
[No Abstract] [Full Text] [Related]
2. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
4. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Moore AY
J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 0.5% colchicine cream versus 5% 5-fluorouracil cream in the treatment of cutaneous field cancerization: a randomized clinical trial.
Teixeira AS; Martins IMC; Miola AC; Miot HA
An Bras Dermatol; 2024; 99(4):527-534. PubMed ID: 38614940
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Knackstedt TJ; Quitadamo M
Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
[TBL] [Abstract][Full Text] [Related]
8. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
9. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
10. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
11. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
12. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
Kaur RR; Alikhan A; Maibach HI
J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
[TBL] [Abstract][Full Text] [Related]
13. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
Martin G
J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
[TBL] [Abstract][Full Text] [Related]
14. Topical therapies for skin cancer and actinic keratosis.
Haque T; Rahman KM; Thurston DE; Hadgraft J; Lane ME
Eur J Pharm Sci; 2015 Sep; 77():279-89. PubMed ID: 26091570
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
16. [Resolution of actinic keratosis with capecetabin].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Nov; 139(11):759-60. PubMed ID: 23199778
[No Abstract] [Full Text] [Related]
17. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
Dohil MA
J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Discontinuation Rate, and Risk Factors for Severe Local Site Reactions with Topical Field Treatment Options for Actinic Keratosis of the Face and Scalp.
Balcere A; Rone Kupfere M; Čēma I; Krūmiņa A
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987411
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.
Askew DA; Mickan SM; Soyer HP; Wilkinson D
Int J Dermatol; 2009 May; 48(5):453-63. PubMed ID: 19416373
[No Abstract] [Full Text] [Related]
[Next] [New Search]